Ultragenyx Pharmaceutical Inc. Operating Margin in % from 2016 to Q3 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Ultragenyx Pharmaceutical Inc. quarterly/annual Operating Margin history and growth rate from 2016 to Q3 2025.
  • Ultragenyx Pharmaceutical Inc. Operating Margin for the quarter ending September 30, 2025 was -86.3 %, a 15.8% increase year-over-year.
  • Ultragenyx Pharmaceutical Inc. annual Operating Margin for 2024 was -95.7 %, a 27% increase from 2023.
  • Ultragenyx Pharmaceutical Inc. annual Operating Margin for 2023 was -131 %, a 26.6% increase from 2022.
  • Ultragenyx Pharmaceutical Inc. annual Operating Margin for 2022 was -179 %, a 64.4% decline from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)

Ultragenyx Pharmaceutical Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -86.3 +16.2 +15.8% Jul 1, 2025 Sep 30, 2025
Q2 2025 -82.8 +31.3 +27.4% Apr 1, 2025 Jun 30, 2025
Q1 2025 -86.9 +44.2 +33.7% Jan 1, 2025 Mar 31, 2025
Q4 2024 -95.7 +35.4 +27% Oct 1, 2024 Dec 31, 2024
Q3 2024 -102 +42 +29.1% Jul 1, 2024 Sep 30, 2024
Q2 2024 -114 +53 +31.7% Apr 1, 2024 Jun 30, 2024
Q1 2024 -131 +42.4 +24.4% Jan 1, 2024 Mar 31, 2024
Q4 2023 -131 +47.5 +26.6% Oct 1, 2023 Dec 31, 2023
Q3 2023 -145 +31.9 +18.1% Jul 1, 2023 Sep 30, 2023
Q2 2023 -167 -26.2 -18.6% Apr 1, 2023 Jun 30, 2023
Q1 2023 -174 -49.5 -39.9% Jan 1, 2023 Mar 31, 2023
Q4 2022 -179 -70 -64.4% Oct 1, 2022 Dec 31, 2022
Q3 2022 -176 -72.1 -69.1% Jul 1, 2022 Sep 30, 2022
Q2 2022 -141 -47.4 -50.7% Apr 1, 2022 Jun 30, 2022
Q1 2022 -124 -29.5 -31.2% Jan 1, 2022 Mar 31, 2022
Q4 2021 -109 +13.2 +10.8% Oct 1, 2021 Dec 31, 2021
Q3 2021 -104 +48.4 +31.7% Jul 1, 2021 Sep 30, 2021
Q2 2021 -93.4 +155 +62.4% Apr 1, 2021 Jun 30, 2021
Q1 2021 -94.6 +271 +74.1% Jan 1, 2021 Mar 31, 2021
Q4 2020 -122 +287 +70.2% Oct 1, 2020 Dec 31, 2020
Q3 2020 -153 +345 +69.3% Jul 1, 2020 Sep 30, 2020
Q2 2020 -249 +308 +55.4% Apr 1, 2020 Jun 30, 2020
Q1 2020 -366 +268 +42.3% Jan 1, 2020 Mar 31, 2020
Q4 2019 -409 +312 +43.3% Oct 1, 2019 Dec 31, 2019
Q3 2019 -498 +506 +50.4% Jul 1, 2019 Sep 30, 2019
Q2 2019 -557 +869 +61% Apr 1, 2019 Jun 30, 2019
Q1 2019 -634 Jan 1, 2019 Mar 31, 2019
Q4 2018 -721 Oct 1, 2018 Dec 31, 2018
Q3 2018 -1K Jul 1, 2018 Sep 30, 2018
Q2 2018 -1.43K Apr 1, 2018 Jun 30, 2018

Ultragenyx Pharmaceutical Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -95.7 +35.4 +27% Jan 1, 2024 Dec 31, 2024
2023 -131 +47.5 +26.6% Jan 1, 2023 Dec 31, 2023
2022 -179 -70 -64.4% Jan 1, 2022 Dec 31, 2022
2021 -109 +13.2 +10.8% Jan 1, 2021 Dec 31, 2021
2020 -122 +287 +70.2% Jan 1, 2020 Dec 31, 2020
2019 -409 +312 +43.3% Jan 1, 2019 Dec 31, 2019
2018 -721 +11.9K +94.3% Jan 1, 2018 Dec 31, 2018
2017 -12.6K +174K +93.2% Jan 1, 2017 Dec 31, 2017
2016 -186K Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.